Skip to content

KLRS KLRS Investment Purchases

Investment Purchases at other companies

Eli Lilly logo
Eli LillyLLY
$297M+50.8%
Merck & Co. logo
Merck & Co.MRK
$374M-37.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$23.92M+10.5%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's investment purchases?
KLRS (KLRS) reported investment purchases of $70.35M in Q1 2026.
How has KLRS's investment purchases changed year-over-year?
KLRS's investment purchases increased by 715.1% year-over-year, from $8.63M to $70.35M.
What is the long-term trend for KLRS's investment purchases?
Over 2 years (2021 to 2025), KLRS's investment purchases has grown at a -32.9% compound annual growth rate (CAGR), from $76.59M to $34.52M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.